News

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.

As the Kansas City Chiefs gear up to head to the Super Bowl, the littlest fans in Chiefs Kingdom suit up for a mini pep rally at Saint Luke’s Hospital of Kansas City's NICU.

Through the Havertys' generosity, the Center has been able to create a national model of care called the Cardiometabolic Center Alliance.

When Shannon Clarke, a 48-year-old, retired police officer, received a heart from Saint Luke’s Mid America Heart Institute, he had no idea just how transformational it would be. 

After he survived a sudden heart attack and found his way to Saint Luke's Mid America Heart Institute, Duane had a procedure that would not only save his life but get him back to truly living.

When Chelsey and Jeremy Heston were expecting their fourth child, they didn’t know if it was going to be a blue or pink surprise, but they did know they would be going to Saint Luke’s. 

Trial device helps Seabrun “Candy” Hunter’s worn heart valve pump at a steady beat.